Phospholipase C-γ as a Potential Therapeutic Target for Graves’ Orbitopathy
Endocrinology and Metabolism · 31.12.2023 · 38 (6) · 739-749
DOI: 10.3803/enm.2023.1780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology and Metabolism, erschienen am 31.12.2023. Verfasst von Tae Hoon Roh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Graves Ophthalmopathy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Yonsei University College of Medicine.
Abstract (Originalsprache)
Background
Phospholipase C-γ (PLC-γ) plays a crucial role in immune responses and is related to the pathogenesis of various inflammatory disorders. In this study, we investigated the role of PLC-γ and the therapeutic effect of the PLC-specific inhibitor U73122 using orbital fibroblasts from patients with Graves’ orbitopathy (GO).
Methods
The expression of phospholipase C gamma 1 (PLCG1) and phospholipase C gamma 2 (PLCG2) was evaluated using polymerase chain reaction in GO and normal orbital tissues/fibroblasts. The primary cultures of orbital fibroblasts were treated with non-toxic concentrations of U73122 with or without interleukin (IL)-1β to determine its therapeutic efficacy. The proinflammatory cytokine levels and activation of downstream signaling molecules were determined using Western blotting.
Results
PLCG1 and PLCG2 mRNA expression was significantly higher in GO orbital tissues than in controls (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.
- Division of Oculofacial Plastic and Reconstructive Surgery, Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA.
- Department of Ophthalmology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Yonsei University College of Medicine
- Soonchunhyang University
Zitieren
APA
Roh, T. H., Chae, M. K., Ko, J. S., Kikkawa, D. O., Jang, S. Y., & Yoon, J. S. (2023). Phospholipase C-γ as a Potential Therapeutic Target for Graves’ Orbitopathy. Endocrinology and Metabolism, 38(6), 739-749. https://doi.org/10.3803/enm.2023.1780
Vancouver
Roh TH, Chae MK, Ko JS, Kikkawa DO, Jang SY, Yoon JS. Phospholipase C-γ as a Potential Therapeutic Target for Graves’ Orbitopathy. Endocrinology and Metabolism. 2023;38(6):739-749. doi:10.3803/enm.2023.1780
BibTeX
@article{Roh2023,
author = {Roh, Tae Hoon and Chae, Min Kyung and Ko, Jae Sang and Kikkawa, Don O and Jang, Sun Young and Yoon, Jin Sook},
title = {Phospholipase C-γ as a Potential Therapeutic Target for Graves’ Orbitopathy},
journal = {Endocrinology and Metabolism},
year = {2023},
volume = {38},
number = {6},
pages = {739--749},
doi = {10.3803/enm.2023.1780}
}
EUVIMED